Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process.

Steven R Danielson1, Valerio Carelli, Guolin Tan

  • 1Department of Molecular Biosciences, University of California Davis, Davis, CA 95616, USA.

Brain : a Journal of Neurology
|February 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same author

An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar Ataxia.

PLoS genetics·2026
Same author

GLP-1 and Parkinson's Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy.

Cells·2026
Same author

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.

The Lancet. Neurology·2026
Same author

A call for action to strengthen stakeholder readiness for ICF data exchange in European health data space: a structured narrative review.

Frontiers in public health·2026
Same author

Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.

Nature medicine·2026

Leber's hereditary optic neuropathy (LHON) is linked to mitochondrial DNA mutations. This study found aldose reductase is overexpressed in LHON cells, suggesting it may be a therapeutic target for this optic nerve disease.

Area of Science:

  • Mitochondrial genetics
  • Neuroscience
  • Cell biology

Background:

  • Leber's hereditary optic neuropathy (LHON) is a common mitochondrial DNA (mtDNA) disorder.
  • Transmitochondrial cytoplasmic hybrid (cybrid) cell lines are key models for studying mitochondrial disease pathogenesis.

Purpose of the Study:

  • To differentiate transcriptomal changes in LHON cybrid cells into rho-zero-dependent, cybridization-dependent, and LHON-dependent categories.
  • To identify specific molecular alterations associated with LHON pathogenesis.

Main Methods:

  • Oligonucleotide microarrays and a novel shared transcript study design.
  • Quantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis.
  • Analysis of transcriptomal and protein level changes in cybrid cells and lymphoblasts.

Related Experiment Videos

Main Results:

  • The rho-zero process had the greatest transcriptomal impact, followed by cybridization, then LHON mutations.
  • LHON mutations led to specific transcriptomal alterations, including overexpression of aldose reductase.
  • Increased aldose reductase and sorbitol levels were observed in LHON cybrid cells and mutant mitochondria.

Conclusions:

  • The rho-zero and cybridization processes significantly impact mitochondrial gene expression, particularly oxidative phosphorylation.
  • Aldose reductase overexpression is a specific finding in LHON, potentially contributing to optic neuropathy.
  • Aldose reductase inhibitors may offer a therapeutic strategy for LHON patients if findings are confirmed in vivo.